Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Inflammation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Inflammation is the body's immune response to harmful stimuli including pathogens, damaged cells, and toxic compounds. In the central nervous system, neuroinflammation plays a dual role: acute inflammation promotes tissue repair and pathogen clearance, while chronic inflammation drives neurodegeneration through oxidative stress, excitotoxicity, and sustained cytokine release.
| Associated Genes | CGAS, ADORA2B, P2RY12, P2RX1, P2RX4, P2RX7, CD38, P2RY1 |
| Therapeutic Agents | Eicosapentaenoic Acid, Sex Hormones, Metformin, Cannabigerol, Gliflozins, Anti-Inflammatory Therapies |
| KG Connections | 5806 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
graph TD
subgraph Pathology["Pathology"]
Inflammation["Inflammation"] -->|"associated with"| Lipid_Metabolism["Lipid Metabolism"]
Inflammation["Inflammation"] -->|"associated with"| Als["Als"]
Inflammation["Inflammation"] -->|"associated with"| Aging["Aging"]
end
subgraph Signaling["Signaling"]
Inflammation["Inflammation"] -->|"activates"| Nf__b["Nf-Kappab"]
Inflammation["Inflammation"] -->|"activates"| Complement["Complement"]
Inflammation["Inflammation"] -->|"activates"| Phagocytosis["Phagocytosis"]
Inflammation["Inflammation"] -->|"activates"| Immune_Response["Immune Response"]
Inflammation["Inflammation"] -->|"activates"| Oxidative_Stress["Oxidative Stress"]
Inflammation["Inflammation"] -.->|"inhibits"| Nf__b_1["Nf-Kappab"]
STING["STING"] -->|"activates"| Inflammation["Inflammation"]
APOE["APOE"] -.->|"inhibits"| Inflammation["Inflammation"]
JUN["JUN"] -->|"activates"| Inflammation["Inflammation"]
CD4["CD4"] -->|"regulates"| Inflammation["Inflammation"]
JUN_2["JUN"] -->|"regulates"| Inflammation["Inflammation"]
end
subgraph Therapeutic["Therapeutic"]
TNF["TNF"] -->|"expressed in"| Inflammation["Inflammation"]
end
style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style Lipid_Metabolism fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Nf__b fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Complement fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Phagocytosis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Immune_Response fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Oxidative_Stress fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Nf__b_1 fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Aging fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style STING fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TNF fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style JUN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CD4 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style JUN_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Lipid Metabolism | associated_with | pathway | 1.00 |
| Nf-Κb | activates | pathway | 1.00 |
| Complement | activates | pathway | 1.00 |
| Phagocytosis | activates | pathway | 1.00 |
| Als | associated_with | disease | 1.00 |
| Immune Response | activates | pathway | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Nf-Κb | inhibits | pathway | 1.00 |
| Aging | associated_with | disease | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| Innate Immunity | activates | pathway | 1.00 |
| Innate Immunity | regulates | pathway | 1.00 |
| Epigenetic | regulates | pathway | 1.00 |
| Epigenetic | activates | pathway | 1.00 |
| Glycolysis | activates | pathway | 1.00 |
| Blood-Brain Barrier | therapeutic_target | pathway | 1.00 |
| Oxidative Stress | associated_with | pathway | 1.00 |
| Tgf-Β | activates | pathway | 1.00 |
| Complement | therapeutic_target | pathway | 1.00 |
| Immune Response | regulates | pathway | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Complement | regulates | pathway | 1.00 |
| Inflammasome | associated_with | pathway | 1.00 |
| Autophagy | therapeutic_target | pathway | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| Immune Response | therapeutic_target | pathway | 1.00 |
| Mtor | therapeutic_target | pathway | 1.00 |
| Ferroptosis | therapeutic_target | pathway | 1.00 |
| Apoptosis | regulates | pathway | 1.00 |
| Apoptosis | inhibits | pathway | 1.00 |
| Glycolysis | regulates | pathway | 1.00 |
| Nf-Κb | regulates | pathway | 1.00 |
| Mtor | regulates | pathway | 1.00 |
| Angiogenesis | therapeutic_target | pathway | 1.00 |
| Blood-Brain Barrier | activates | pathway | 1.00 |
| Oxidative Stress | inhibits | pathway | 1.00 |
| Senescence | associated_with | disease | 1.00 |
| Blood-Brain Barrier | associated_with | pathway | 1.00 |
| Autophagy | inhibits | pathway | 1.00 |
| Inflammasome | activates | pathway | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Toll-Like Receptor | activates | pathway | 1.00 |
| Adaptive Immunity | activates | pathway | 1.00 |
| Autophagy | associated_with | pathway | 1.00 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 1.00 |
| Mapk | inhibits | pathway | 1.00 |
| Autoimmune | associated_with | disease | 1.00 |
| Oxidative Stress | regulates | pathway | 1.00 |
| Autophagy | regulates | pathway | 1.00 |
| Nf-Κb | associated_with | pathway | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| STING | activates | gene | 1.00 |
| TNF | expressed_in | gene | 1.00 |
| APOE | inhibits | gene | 1.00 |
| JUN | activates | gene | 1.00 |
| CD4 | regulates | gene | 1.00 |
| JUN | regulates | gene | 1.00 |
| OVERVIEW | regulates | gene | 1.00 |
| NLRP3 | associated_with | gene | 1.00 |
| MTOR | therapeutic_target | gene | 1.00 |
| BAX | inhibits | gene | 1.00 |
| TNF | inhibits | gene | 1.00 |
| TREM2 | activates | gene | 1.00 |
| OVERVIEW | therapeutic_target | gene | 1.00 |
| MTOR | regulates | gene | 1.00 |
| NRF2 | activates | gene | 1.00 |
| TNF | activates | gene | 1.00 |
| SIRT1 | activates | gene | 1.00 |
| GFAP | biomarker_for | gene | 1.00 |
| APOE | therapeutic_target | gene | 1.00 |
| IL6 | inhibits | gene | 1.00 |
| ATG5 | inhibits | gene | 1.00 |
| NLRP3 | inhibits | gene | 1.00 |
| ATG5 | activates | gene | 1.00 |
| ASC | activates | gene | 1.00 |
| NLRP3 | activates | gene | 1.00 |
| TLR4 | activates | gene | 1.00 |
| OVERVIEW | activates | gene | 1.00 |
| TLR4 | inhibits | gene | 1.00 |
| BDNF | activates | gene | 1.00 |
| CD8 | activates | gene | 1.00 |
| STAT3 | activates | gene | 1.00 |
| TNF | regulates | gene | 1.00 |
| MTOR | activates | gene | 1.00 |
| NRF2 | regulates | gene | 1.00 |
| OVERVIEW | associated_with | gene | 1.00 |
| NRF2 | therapeutic_target | gene | 1.00 |
| CGAS | activates | gene | 1.00 |
| SQSTM1 | activates | gene | 1.00 |
| MMP9 | therapeutic_target | gene | 1.00 |
| STAT3 | regulates | gene | 1.00 |
| GAIN | activates | gene | 1.00 |
| STING | therapeutic_target | gene | 1.00 |
| GFAP | activates | gene | 1.00 |
| APOE | associated_with | gene | 1.00 |
| APOE | regulates | gene | 1.00 |
| TNF | associated_with | gene | 1.00 |
| Stroke | associated_with | disease | 1.00 |
| Atherosclerosis | associated_with | disease | 1.00 |
| Cardiovascular | associated_with | disease | 1.00 |
| GENES | activates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone | 0.645 | neurodegeneration | What are the precise temporal dynamics o |
| STING Antagonism Prevents Acute-to-Chronic Neuroinflammation | 0.605 | neuroinflammation | What molecular mechanisms drive the tran |
| Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 | 0.601 | neurodegeneration | What are the mechanisms by which gut mic |
| Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio | 0.486 | translational neuroscience | Which metabolic biomarkers can distingui |
| Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Pha | 0.452 | Alzheimer's disease | TREM2 agonism vs antagonism in DAM micro |
| Cardiovascular-Neuroinflammation Crosstalk Interruption | 0.437 | Alzheimer's disease | Neuroinflammation and microglial priming |
Scientific analyses that reference this entity
neuroinflammation | 2026-04-15 | 2 hypotheses Top: 0.605
neurodegeneration | 2026-04-14 | 0 hypotheses
neuroinflammation | 2026-04-13 | 2 hypotheses Top: 0.632
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.473
neurodegeneration | 2026-04-13 | 1 hypotheses Top: 0.584
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for S [PMID:41114949] | Ding YN, Li MQ, Ding PT, Wang P, Guan PP | Nano letters | 2026 | 1 |
| Systemic inflammation as a central player in the initiation and development of A [PMID:40841660] | Bayraktaroglu I, Ortí-Casañ N, Van Dam D | Immunity & ageing : I & A | 2025 | 1 |
| Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibi [PMID:40050873] | Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding | Journal of nanobiotechnology | 2025 | 1 |
| Interactions between antidiabetes medications and heart-brain axis. [PMID:39639832] | Ong LT, Sia CH | Current opinion in endocrinolo | 2025 | 1 |
| The Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Rev [PMID:40507911] | Popa E, Popa AE, Poroch M, Poroch V, Ung | International journal of molec | 2025 | 1 |
| Obesity-induced pyroptotic adipocyte death leads to TREM2-dependent macrophage d [PMID:41509917] | Choi C, Lee J, Park G, Namgoong S, Lee Y | iScience | 2026 | 0 |
| Air pollution, glymphatic impairment, and Alzheimer's disease. [PMID:37777345] | Hussain R, Graham U, Elder A, Nedergaard | Trends in neurosciences | 2023 | 0 |
| Molecular biomarkers for vascular cognitive impairment and dementia. [PMID:37957261] | Hosoki S, Hansra GK, Jayasena T, Poljak | Nature reviews. Neurology | 2023 | 0 |